Anticancer Properties of 4-(2-Aminoethyl) benzenesulfonamide Derivatives: Selective Cytotoxicity, Apoptosis, and Increased Reactive Oxygen Species in HeLa Cells
Translational Biochemistry and Metabolomics · 14.10.2026 · 1 (1) · 10-16
DOI: 10.71350/tbm.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Biochemistry and Metabolomics, online erschienen am 14.10.2026. Verfasst von Ismail Koyuncu und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Carbonic anhydrase IX (CA-IX) is a hypoxia-regulated transmembrane enzyme that supports pH homeostasis in tumor cells; it is highly expressed in many solid tumors but is present at limited levels in most normal tissues.
Methods
In this study, the anticancer activity of four newly synthesized 4-(2-aminoethyl) benzenesulfonamide derivatives (H-3, H-4, H-3i, and H-4i) exhibiting CA-IX inhibitory activity was evaluated. The cytotoxicity of the compounds was examined using the WST-1 assay in CA-IX-expressing HeLa cervical adenocarcinoma cells, MDA-MB-231 breast adenocarcinoma cells, and normal PNT-1A prostate cells following 24-, 48-, and 72-hour treatments at concentrations ranging from 0 to 200 µM. The most effective compound was also evaluated using BrdU incorporation, Annexin V/propidium iodide flow cytometry, and DCFDA-based reactive oxygen species (ROS) analysis.
Results
H-4 exhibited the strongest cytotoxic effect in HeLa cells at 72 hours with an IC50 value of 13.7 µM; the same value was 37.3 µM in MDA-MB-231 cells and 202.6 µM in PNT-1A cells. The efficacy of H-4 in HeLa cells was comparable to that of 5-fluorouracil (14.7 µM) but lower than that of cisplatin (6.1 µM); its toxicity to PNT-1A cells was significantly lower than that of both reference drugs. H-4 inhibited HeLa proliferation (BrdU IC50: 18.14 µM), increased the proportions of early and late apoptotic cells, and caused a dose-dependent increase in intracellular ROS levels.
Conclusion
The findings indicate that H-4 is a promising lead compound exhibiting selective activity against HeLa cells and that it requires validation through further mechanistic, three-dimensional culture, and in vivo studies.
Zitieren
APA
Koyuncu, I., Umurhan, B., Demirkıran, S., Yüksekdag, O., Coskun, M. B., Durgun, M., Tiken, M., & Temiz, E. (2026). Anticancer Properties of 4-(2-Aminoethyl) benzenesulfonamide Derivatives: Selective Cytotoxicity, Apoptosis, and Increased Reactive Oxygen Species in HeLa Cells. Translational Biochemistry and Metabolomics, 1(1), 10-16. https://doi.org/10.71350/tbm.2
Vancouver
Koyuncu I, Umurhan B, Demirkıran S, Yüksekdag O, Coskun MB, Durgun M, et al. Anticancer Properties of 4-(2-Aminoethyl) benzenesulfonamide Derivatives: Selective Cytotoxicity, Apoptosis, and Increased Reactive Oxygen Species in HeLa Cells. Translational Biochemistry and Metabolomics. 2026;1(1):10-16. doi:10.71350/tbm.2
BibTeX
@article{Koyuncu2026,
author = {Koyuncu, Ismail and Umurhan, Berrin and Demirkıran, Seyda and Yüksekdag, Ozgur and Coskun, Mehmet Burak and Durgun, Mustafa and Tiken, Murat and Temiz, Ebru},
title = {Anticancer Properties of 4-(2-Aminoethyl) benzenesulfonamide Derivatives: Selective Cytotoxicity, Apoptosis, and Increased Reactive Oxygen Species in HeLa Cells},
journal = {Translational Biochemistry and Metabolomics},
year = {2026},
volume = {1},
number = {1},
pages = {10--16},
doi = {10.71350/tbm.2}
}
EUVIMED